Fritextsökning
Innehållstyper
-
Networking event in Denmark: Sponsor Oversight in Clinical Trials
We are excited to invite clinical trial professionals to a networking event to connect and discuss best practices, challenges and adaptive strategies in documen...
-
Thermo Fisher’s lab in Gothenburg opens
Thermo Fisher’s clinical research business, PPD, is opening its first bioanalytical laboratory in Europe. The company chose Gothenburg for the new facility, whi...
-
AI-bolag tar in 20 miljarder för läkemedelsdesign
Somliga unga biotechbolag har lättare än andra att hitta finansiering. Brittiska Isomorphic Labs har i dagarna lyckats ta in 2,1 miljarder dollar, motsvarande n...
-
Uppsalabolag tar in 210 miljoner för klinisk studie
Dicot Pharma har beslutat om en nyemission på upp till 210 miljoner kronor för att finansiera en planerad fas IIb-studie inom erektil dysfunktion.
-
New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Copenhagen (2026)
-
Lilly kliver djupare in i ADC‑racet
Ett nytt förvärv ska stärka Eli Lillys position inom det snabbt växande området antikroppsläkemedelskonjugat (ADC).
-
Study: Autism as common in girls as in boys
Autism may be just as common in girls as in boys, but girls are diagnosed significantly later and less often during childhood, according to a large Swedish registry study.
-
Medicon Village breakfast seminar: ISO 10993-1 in practice
Don't miss our breakfast seminar at Medicon Village on May 28th: ISO 10993-1 in practice - connecting biological evaluation to your technical documentation.
-
Eli Lilly går in i racet om in vivo CAR-T
Eli Lilly förvärvar Orna Therapeutics. Därmed får läkemedelsjätten tillgång till en ny teknologiplattform inom ett allt hetare område: in vivo CAR-T.
-
Meet ZEISS at ELRIG Advances in Cell-based Screening 2026
Reserve your spot now.
-
Hajpad genterapi mot blödarsjuka dras in
Roctavian, den första och enda genterapin mot hemofili A, dras in från marknaden. Orsaken är att den blivit en kommersiell flopp.
-
Moleculent tar in 185 miljoner – ”Marknaden signalerar att den är redo”
Svenska Moleculent, som utvecklar avancerade forskningsinstrument, har tagit in 20 miljoner dollar – motsvarande 185 miljoner kronor – i en finansieringsrunda s...
-
Eli Lilly köper in vivo CAR-T-bolag för miljardbelopp
Amerikanska läkemedelsjätten fortsätter att satsa på nästa generations cellterapi. Nu köper bolaget Kelonia Therapeutics i en affär värd upp till 7 miljarder dollar.
-
Why Data and AI Skills Are Becoming Critical in Life Science Teams
Life Science organizations are investing heavily in data platforms, digital tools and AI driven solutions. From production and quality to clinical development a...
-
ZEISS and EDGE leverage AI to transform bioimaging in the biopharma industry
Transforming complex bioimaging data to workflows offering actionable insights for decision-making to speed up drug discovery.
-
International medical graduates leave Sweden in high numbers
Three years after completing their studies, 46 percent of international doctoral students who graduated in the medical field had left the country. This is shown...
-
Nordic collaboration delivering the next leap in spatial biology
Spatial biology is reshaping how researchers understand complex tissue environments, from tumour–immune interactions to treatment response. A major barrier has ...
-
Disappointment for Diamyd in Phase III – the share price plunges
Diamyd Medical’s share was sharply down on Monday following negative Phase III results. “This outcome is highly unexpected,” said the company’s CEO, Ulf Hannelius.
-
Insurance in Life Science: From risk to resilience
Are you visiting The Future of Swedish & Danish Life Science event in Lund 23 April? Don't miss the Gallagher seminar on Risk and Insurance in the Life Sciences sector.
-
Webinar: Imaging of Complex In-Vitro Models
Deep Imaging and Scalable Analysis of Hepatic Spheroids with ZEISS LSM 910/990 Lightfield 4D.
-
Quality management system according to EN ISO 13485:2016 – in practice
Do you work with medical devices? Understanding and implementing a robust Quality Management System (QMS) is key to regulatory success—and often a prerequisite for CE-marking.
-
Lost in the recruitment process? How hiring really works today
As recruitment becomes increasingly automated, candidates are expected to adapt to both human and algorithmic decision-making. Career coach Tina Persson outline...
-
Thermo Fisher Expands in Sweden – “We Are Sending a Clear Message”
The American life science giant Thermo Fisher Scientific has inaugurated a new distribution center in Uppsala. “By investing in increasing our capacity as well ...
-
Breakfast meeting in Norway: Essential Insights for Life Science Leaders on AI and Patient Journeys
We are pleased to invite you to an inspiring session with Niels Buch Leander, Chief Digital Officer at PharmaRelations.